Drug Trial Radar · NCT07010406
A Study to Evaluate the Relative Bioavailability of Povetacicept Formulations and Bioequivalence of Povetacicept Presentations
Last checked: Nov 20, 2026Latest source record: Sep 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Jun 6, 2025
Primary completion
Aug 19, 2025
Study completion Aug 19, 2025
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Jun 8, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the relative bioavailability of Povetacicept formulations, bioequivalence of Povetacicept presentations, and safety and tolerability of Povetacicept.
Conditions
- Healthy Volunteers
Interventions
PovetaciceptDrug
Injection for Subcutaneous Administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Concentration Versus Time Curve From the Time of Dosing to 28 Days (AUC0-28d) of Free PovetaciceptTime frame: From Day 1 up to Day 30
- Maximum Observed Plasma Concentration (Cmax) of Free PovetaciceptTime frame: From Day 1 up to Day 30
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Celerion - Tempe
Tempe, Arizona
Celerion - Lincoln
Lincoln, Nebraska
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.